Acrodermatitis continua of Hallopeau: a review and update on biological and small molecule targeted immunomodulatory therapies
Acrodermatitis continua of Hallopeau (ACH) is a rare aseptic pustular dermatosis for which clinical guidelines are lacking and treatment is largely based on case reports. Biologically targeted therapies offer new therapeutic ideas, with TNF antagonists such as adalimumab showing promising efficacy i...
Saved in:
| Main Authors: | Qiong Sun, Luyao Han, Zhimin Lin, Yuanhao Wu, Chen Li, Zhenhua Ying, Zuotao Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1525821/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apremilast Coadministered with Secukinumab for Effective Treatment of Acrodermatitis Continua of Hallopeau: A Case Report
by: Yao XY, et al.
Published: (2025-05-01) -
Acrodermatitis continua of hallopeau: aggravating factors and treatment outcomes of 96 patients
by: Liyan Yuan, et al.
Published: (2024-12-01) -
Spesolimab in generalized pustular psoriasis complicated by acrodermatitis continua of Hallopeau: a case report and mechanistic insights
by: Xin-Yi Hou, et al.
Published: (2025-05-01) -
Acrodermatitis Continua of Hallopeau and Generalised Pustular Psoriasis: Case Reports of Two Different Manifestations of IL36RN Mutation in Siblings
by: Gu M, et al.
Published: (2025-03-01) -
State-of-the-Art Review on the Treatment of Axial Spondyloarthritis
by: Evripidis Kaltsonoudis, et al.
Published: (2025-03-01)